Finch Therapeutics Group, Inc. Q1 FY2022 Earnings Call

Finch Therapeutics Group, Inc. (FNCHQ)

Earnings Call FY2022 Q1 Call date: 2022-05-16 Concluded

Quarter scorecard

Revenue

$354,000

-90% YoY

Diluted EPS

$-15.60

Net income

-$24.57M